Verita Signs Jv Agreement to Build Largest GMP Compound Pharmaceutical Manufacturing Facility in Se Asia
March 25, 2015
Singapore, 30 March 2015 – Verita Healthcare Group (“Verita”), through its wholly owned subsidiary Verita Innovate Pte Ltd, has signed a JV agreement with Australian Custom Pharmaceuticals Pty Ltd to establish a 51:49 compounding pharmacy facility in Iskandar Malaysia to be called Auscustom Pharma Sdn Bhd. Auscustom Pharma Sdn Bhd when completed will be the largest GMP Compound Pharmaceutical facility in SE Asia with a Pharmacy license capable of flexible and innovative production centered on a robust R&D approach.
Investment in a collaborative Research and Development strategy partnering with International and Local Universities/Institutes in development of medical solutions in the field of proteomics, integrative oncology and culturally sensitive (i.e. halal) health solutions.
The plant will be accredited with both Host nation (i.e. BPFK GMP) Licensing and Australian TGA GMP license specifically for the purpose of supplying Regional export markets (80%) and host country (up to 20%)
The plants range of core competencies will encompass sterile medications in prefilled syringe, cartridges, elastomeric pumps and EVA Bags through to Peptides and Oncology products.
Dissemination of world class IP employed exclusively in the production facility is at the heart of our Strategic differentiation
Australian Custom Pharmaceuticals Pty Ltd is an Integrative Manufacturer of Medicines and Preparations who for nearly 15 years have been developing and formulating innovative Dose Delivery Systems and catering for Medication shortages and Orphan Products in the Australian healthcare system.